Moody National Bank Trust Division’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$794K Sell
1,274
-8
-0.6% -$5.45K 0.07% 273
2026
Q1
$991K Sell
1,282
-5
-0.4% -$3.83K 0.09% 208
2025
Q4
$993K Sell
1,287
-499
-28% -$339K 0.1% 220
2025
Q3
$1M Buy
1,786
+288
+19% +$163K 0.08% 252
2025
Q2
$786K Sell
1,498
-53
-3% -$29.6K 0.07% 285
2025
Q1
$984K Buy
1,551
+53
+4% +$36.5K 0.1% 231
2024
Q4
$1.07M Buy
+1,498
New +$1.26M 0.11% 220
2023
Q4
Sell
-1,146
Closed -$943K 619
2023
Q3
$943K Buy
1,146
+16
+1% +$12.6K 0.06% 232
2023
Q2
$812K Hold
1,130
0.06% 262
2023
Q1
$928K Hold
1,130
0.08% 222
2022
Q4
$816K Hold
1,130
0.07% 230
2022
Q3
$778K Buy
1,130
+16
+1% +$10.1K 0.08% 225
2022
Q2
$659K Buy
+1,114
New +$724K 0.07% 239
2019
Q2
Sell
-67
Closed -$28K 832
2019
Q1
$28K Buy
67
+11
+20% +$4.53K ﹤0.01% 489
2018
Q4
$21K Buy
+56
New +$20.5K ﹤0.01% 465

Other funds holding REGN

Moody National Bank Trust Division's REGN Position: Q2 2026 in Review

Moody National Bank Trust Division reduced its Regeneron Pharmaceuticals (REGN) stake by 0.62% in Q2 2026, selling an estimated $5.45K and leaving 1,274 shares worth $794K. The position accounts for 0.07% of the portfolio, ranked #273.

Moody National Bank Trust Division first reported a position in REGN in Q4 2018 and has held it in 15 quarters since. The position peaked at $1.07M in Q4 2024. 518 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Moody National Bank Trust Division held 1,274 shares of Regeneron Pharmaceuticals worth $794K as of Q2 2026.
  • Moody National Bank Trust Division sold 8 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $5.45K.
  • Regeneron Pharmaceuticals made up 0.07% of Moody National Bank Trust Division's portfolio in Q2 2026, its #273 holding.
  • Moody National Bank Trust Division first reported a position in Regeneron Pharmaceuticals in Q4 2018 and has held it in 15 quarters since.
  • Moody National Bank Trust Division's Regeneron Pharmaceuticals position peaked at $1.07M in Q4 2024.
  • 518 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Moody National Bank Trust Division's 13F filing for Q2 2026, filed 7 Jul 2026.